Align Expertise’s board of administrators has licensed a brand new inventory repurchase program price US$1 billion, following the completion of its earlier US$1-billion buyback on Could 1.
The brand new program permits Align to repurchase as much as US$1 billion of its widespread inventory over the subsequent three years. The prior authorization, authorised in January 2023, was accomplished on Could 1, 2025, with settlement on Could 2.
The announcement follows the discharge of Align’s first-quarter 2025 monetary outcomes on April 30, which confirmed a slight decline in complete income however beat earnings expectations. In April, Morgan Stanley additionally diminished Align’s value goal from US$272 to US$249 however maintained its “obese” score, indicating continued confidence within the firm’s potential.
“The brand new US$1-billion program displays the power of our steadiness sheet and money move era.” John Morici, Align’s CFO and govt vice-president, international finance.
“The brand new US$1-billion program displays the power of our steadiness sheet and money move era, in addition to administration’s and our board’s continued confidence in our skill to capitalize on giant market alternatives in our goal markets and trajectory for progress,” stated John Morici, Align’s CFO and govt vice-president, international finance. “Returning capital to our shareholders by way of inventory repurchase applications, whereas concurrently investing in our strategic progress drivers, is in line with our capital allocation technique and dedication to growing shareholder worth.”
As of March 31, Align had roughly 73.1 million shares excellent and US$873 million in money and money equivalents.
Additionally learn: Dental shares downgraded? Right here is all the pieces you’ll want to know as a dentist
Additionally learn: Stats Canada: Dental sector surpasses pre-pandemic productiveness ranges by $851 million as job progress rebounds
Q1 report
In late April, the corporate reported Q1 revenues of US$979.3 million, marking a 1.8 per cent lower year-over-year. Nevertheless, Clear Aligner quantity elevated by 6.2 per cent to 642,300 circumstances, with therapies for teenagers and rising sufferers rising 13.3 per cent to 225,800 circumstances, pushed by continued adoption of Invisalign First.
Regardless of headwinds from unfavourable overseas change, Align reported a non-GAAP diluted earnings per share of US$2.13 in Q1 2025, surpassing the US$2.00 analysts’ forecast and demonstrating operational resilience.
For the second quarter, Align expects worldwide revenues to vary from US$1.05 billion to US$1.07 billion, up from Q1.
“We’ve assessed the potential affect of China’s retaliatory tariffs and imagine that we’re capable of mitigate many of the tariff.” Align’s assertion.
Tariff outlook stays unsure
Align additionally addressed potential tariff impacts in its earnings launch. The corporate stated it expects an “incremental tariff, if applied, to be utilized to switch costs on items shipped from Mexico.”
“As famous in President Trump’s govt order dated April 2, 2025, USMCA-compliant items are exempt from the tariffs underneath the order. Nevertheless, the U.S.-Mexico tariff scenario stays fluid, and we’re unable to foretell whether or not USMCA-compliant merchandise will stay exempt, whether or not there shall be different modifications to the introduced order, or if extra tariffs shall be imposed sooner or later,” the corporate stated.
Align added it doesn’t anticipate important tariff impacts on its operations in China, the place Clear Aligners are made for the Asian market.
“We’ve assessed the potential affect of China’s retaliatory tariffs and imagine that we’re capable of mitigate many of the tariff publicity by way of changes in our provide chain,” it stated.
